Clinical trial
Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel…
NCT00441766 · Allergan, Industry · Terminated
Key facts
| NCT number | NCT00441766 |
|---|---|
| Title | Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain |
| Lead sponsor | Allergan, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | AGN 203818, placebo |
| Enrollment | 213 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Mar 1, 2007 |
| Last update posted | Jan 20, 2012 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: